The economic and social impact of chronic brain disorders (CBD) such as Alzheimer’s disease (AD) and other neurodegenerative diseases will become the number one public-health problem worldwide, directly affecting 100 million people by 2050. On-going demographic trends, namely ageing populations worldwide, are leading to the unprecedented expansion of consumer demand for healthcare services. Healthcare systems worldwide soon will confront a serious crisis as a result of significant growth of the healthcare market, in a climate of shrinking resources.
Emerging Trends in Biomedicine and Health Technology Innovation
Addressing the Global Challenge of Alzheimer's
Policy paper
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
21 May 202645 Pages -
Policy paper
Trends and priorities, 2019‑2023
20 May 202648 Pages -
4 December 202563 Pages
-
1 December 202537 Pages
-
Policy paper
A case study within the OECD’s Global Green Iron project
22 October 202564 Pages
Related publications
-
23 March 202637 Pages
-
6 February 202626 Pages
-
30 January 202672 Pages
-
22 January 202688 Pages
-
8 December 202545 Pages
-
4 December 202563 Pages
-
20 October 202555 Pages
-
Policy paper
Key considerations from peers’ experience
29 September 202539 Pages